文献速递妇科

融入改良无瘤技术的腹腔镜根治性子宫切除术的肿瘤学结局

Oncologic Outcomes of Laparoscopic Radical Hysterectomy Incorporating Modified Tumor-Free Techniques.
PubMed 文献 · Obstet Gynecol · 2024-12-19

单中心回顾性队列研究纳入276例早期宫颈癌患者,比较改良无瘤技术腹腔镜根治性子宫切除术(MTF组151例)与常规腹腔镜根治性子宫切除术(非MTF组125例)的肿瘤学结局。中位随访36.0个月和66.8个月,MTF组复发2例(1.3%),非MTF组16例(12.8%);2年无病生存率分别为99.3%和91.9%,调整后多因素分析显示改良无瘤技术是更长无病生存的独立预测因素(HR 0.10,95%CI 0.01-0.77,P=.027)。

要点

  • MTF组住院时间短于非MTF组,手术时间、血红蛋白下降及并发症无显著差异。
  • MTF组复发2例(1.3%),非MTF组16例(12.8%)。
  • 2年无病生存率MTF组99.3%,非MTF组91.9%。

核心结论

  • 融入改良无瘤技术的腹腔镜根治性子宫切除术是早期宫颈癌患者的可行治疗方式。
  • 接受该术式患者的肿瘤学结局优于常规腹腔镜根治性子宫切除术患者。

研究设计与样本

  • 单中心回顾性队列研究,纳入2017年1月至2023年1月治疗的276例早期宫颈癌患者。
  • MTF组151例接受融入改良无瘤技术的腹腔镜根治性子宫切除术。
  • 非MTF组125例接受使用举宫器及无保护腹腔内阴道切开术的常规腹腔镜根治性子宫切除术。
  • 采用逆概率治疗加权(IPTW)分析肿瘤学结局和围手术期结果。

主要发现

  • MTF组住院时间短于非MTF组。
  • 手术时间、血红蛋白下降及并发症在两组间无显著差异。
  • MTF组中位随访36.0个月(范围15.3-62.0个月),非MTF组66.8个月(范围3.0-82.5个月)。
  • 复发MTF组2例(1.3%),非MTF组16例(12.8%)。
  • 2年无病生存率MTF组99.3%,非MTF组91.9%。

关键数值与推荐

  • 限于2年生存的主要分析中,调整后多因素分析显示改良无瘤技术的使用是更长无病生存的独立预测因素(HR 0.10,95%CI 0.01-0.77,P=.027)。
  • IPTW后,MTF组无病生存优于非MTF组(log-rank P=.031)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: It remains unclear whether modifying laparoscopic radical hysterectomy to adopt tumor-free principles can improve oncologic outcomes in patients with early-stage cervical cancer. METHODS: We performed a single-center retrospective cohort study of 276 patients with early-stage cervical cancer who were treated between January 2017 and January 2023, including 151 patients who underwent laparoscopic radical hysterectomy that incorporated modified tumor-free techniques (MTF group) and 125 patients who underwent conventional laparoscopic radical hysterectomy with a uterine manipulator and unprotected intracorporeal colpotomy (non-MTF group). Oncologic outcomes and perioperative results were analyzed using inverse probability treatment weighting (IPTW). RESULTS: Patients in the MTF group had shorter length of hospital stay than those in the non-MTF group. However, there were no significant differences in operative time, decrease in hemoglobin, or complications. After a median follow-up of 36.0 months (range 15.3-62.0 months) for the MTF group and 66.8 months (range 3.0-82.5 months) for the non-MTF group, recurrence was observed in two (1.3%) and 16 (12.8%) of the patients, respectively. The 2-year disease-free survival (DFS) rates in the MTF group and non-MTF group were 99.3% and 91.9%, respectively. In the primary analysis limited to 2-year survival, the adjusted multivariate analysis showed that use of modified tumor-free techniques was an independent predictor of longer DFS (hazard ratio 0.10 95% CI, 0.01-0.77, P =.027). After IPTW, patients in the MTF group had a more favorable DFS than those in the non-MTF group (log-rank P =.031). CONCLUSION: Laparoscopic radical hysterectomy that incorporates modified tumor-free techniques is a feasible treatment for patients with early-stage cervical cancer. Oncologic outcomes of individuals who underwent this procedure were more favorable than those of conventional laparoscopic radical hysterectomy.

来源:Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Li Y, Zhao J, Ding X, et al. Oncologic Outcomes of Laparoscopic Radical Hysterectomy Incorporating Modified Tumor-Free Techniques. Obstet Gynecol. 2024. PMID: 39700500. doi:10.1097/AOG.0000000000005805

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。